Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Geographic origin and evolution of dengue virus serotypes 1 and 3 circulating in Africa.
Nyathi S, Rezende IM, Walter KS, Thongsripong P, Mutuku F, Ndenga B, Mbakaya JO, Agola G, Vu DM, Bennett S, Mordecai EA, Andrews JR, LaBeaud AD. Nyathi S, et al. Among authors: rezende im. Virus Evol. 2024 Dec 30;11(1):veae116. doi: 10.1093/ve/veae116. eCollection 2025. Virus Evol. 2024. PMID: 39839680 Free PMC article.
Molecular epidemiology and evolutionary characteristics of dengue virus 2 in East Africa.
Nyathi S, Rezende IM, Walter KS, Thongsripong P, Mutuku F, Ndenga B, Mbakaya JO, Aswani P, Musunzaji PS, Chebii PK, Maina PW, Mutuku PS, Ng'ang'a CM, Malumbo SL, Jembe Z, Vu DM, Mordecai EA, Bennett S, Andrews JR, LaBeaud AD. Nyathi S, et al. Among authors: rezende im. Nat Commun. 2024 Sep 7;15(1):7832. doi: 10.1038/s41467-024-51018-0. Nat Commun. 2024. PMID: 39244569 Free PMC article.
Corrigendum: Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil.
de Oliveira LA, de Rezende IM, Navarini VJ, Marchioro SB, Torres AJL, Croda J, Croda MG, Gonçalves CCM, Xavier J, de Castro E, Lima M, Iani F, Adelino T, Aburjaile F, Ferraz Demarchi LH, Taira DL, Zardin MCSU, Fonseca V, Giovanetti M, Andrews J, Alcantara LCJ, Simionatto S. de Oliveira LA, et al. Among authors: de rezende im. Front Public Health. 2024 Jul 31;12:1461598. doi: 10.3389/fpubh.2024.1461598. eCollection 2024. Front Public Health. 2024. PMID: 39145176 Free PMC article.
Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study.
Rezende IM, Mendonça DC, Costa TA, de Oliveria GFG, Arruda MS, Gonçalves AP, Alves PA, Calzavara-Silva CE, Martins-Filho OA, Teixeira-Carvalho A, Bonjardim CA, Monath TP, LaBeaud AD, Drumond BP, Pascoal-Xavier MA, Pereira LS, Ramalho DB. Rezende IM, et al. Open Forum Infect Dis. 2024 Jun 6;11(6):ofae312. doi: 10.1093/ofid/ofae312. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38933737 Free PMC article.
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.
Gonçalves AP, Almeida LT, Rezende IMd, Fradico JRB, Pereira LS, Ramalho DB, Pascoal Xavier MA, Calzavara Silva CE, Monath TP, LaBeaud AD, Drumond BP, Campi-Azevedo AC, Martins-Filho OA, Teixeira-Carvalho A, Alves PA; Grupo de Estudos de Pesquisa e Resposta em Febre Amarela do Estado de Minas Gerais. Gonçalves AP, et al. Among authors: rezende imd. Microbiol Spectr. 2024 May 2;12(5):e0370323. doi: 10.1128/spectrum.03703-23. Epub 2024 Mar 21. Microbiol Spectr. 2024. PMID: 38511952 Free PMC article.
Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil.
de Oliveira LA, de Rezende IM, Navarini VJ, Marchioro SB, Torres AJL, Croda J, Croda MG, Gonçalves CCM, Xavier J, de Castro E, Lima M, Iani F, Adelino T, Aburjaile F, Ferraz Demarchi LH, Taira DL, Zardin MCSU, Fonseca V, Giovanetti M, Andrews J, Alcantara LCJ, Simionatto S. de Oliveira LA, et al. Among authors: de rezende im. Front Public Health. 2023 Oct 26;11:1195779. doi: 10.3389/fpubh.2023.1195779. eCollection 2023. Front Public Health. 2023. PMID: 37965526 Free PMC article.
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever.
Rezende IM, McClure MA, Pereira LS, Fradico JRB, Cenachi ARC, Moura AS, Paladino LLA, Dutra MRT, Alves PA, Xavier MAP, Said RFDC, Ramalho DB, Gama TDP, Martins-Filho OA, Monath TP, Teixeira-Carvalho A, Drumond BP, LaBeaud AD; Yellow Fever Collaborative Group. Rezende IM, et al. Clin Infect Dis. 2023 Aug 22;77(4):565-573. doi: 10.1093/cid/ciad249. Clin Infect Dis. 2023. PMID: 37099356 Free PMC article.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Fradico JRB, Campi-Azevedo AC, Speziali E, do Valle Antonelli LR, Peruhype-Magalhães V, de Rezende IM, Alves PA, Pascoal-Xavier MA, Pereira LS, Dutra MRT, Ramalho DB, Cenachi A, de Paula L, Santos TA, do Carmo Said RF, Calzavara-Silva CE, Coelho-Dos-Reis JGA, de Magalhães CR, Rabelo LLC, Valim V, Brito-de-Sousa JP, da Costa-Rocha IA, de Souza Gomes M, Amaral LR, de Lima SMB, Trindade GF, Santos RT, da Silva JFA, Monath T, LaBeaud AD, Drumond BP, Martins-Filho OA, Teixeira-Carvalho A; Yellow Fever Collaborative Group. Fradico JRB, et al. Among authors: de rezende im. Clin Immunol. 2023 Jun;251:109321. doi: 10.1016/j.clim.2023.109321. Epub 2023 Apr 3. Clin Immunol. 2023. PMID: 37019421
Urban risk factors for human Rift Valley fever virus exposure in Kenya.
Gerken KN, Mutuku FM, Ndenga BA, Agola GA, Migliore E, Fabre EP, Malumbo S, Shaita KN, Rezende IM, LaBeaud AD. Gerken KN, et al. Among authors: rezende im. PLOS Glob Public Health. 2022 Jul 14;2(7):e0000505. doi: 10.1371/journal.pgph.0000505. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962424 Free PMC article.
24 results